SCureClamp - Unique Mechanical Surgical Clamping System with Interdigitation Occlusion Technology (iDOT)
CE mark and FDA cleared SCureClamp with Interdigitation Occlusion Technology (iDOT) is designed to easily and securely close vessels – veins, arteries, and tubular structures – during surgical and interventional procedures. This unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasively, 18 G needle for clamping of blood vessels, ducts, arteries, and veins. The minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture. SCureClamp with iDOT’s anchoring feature secures the implant in place and eliminates slippage. Grasping allows physicians to occlude vessels of varying sizes, types and wall thickness.
- Permanent
- Non-Chemical
- Non-Thermal
- Non-Tumescent
- No Compression
- Ultrasound Guided
- Targeting 18 G Needle Delivery
Current treatments for venous disease do not typically provide a permanent solution. Without effective occlusion, physicians are seeing ulcer recurrence, rising costs, and severe patient morbidity.
Perforator treatments such as lasers, RF, glue, and sclerotheray average a 75-80% efficacy rate.
The temporary clamping device is targeted at reducing front-line deaths associated with non-compressible and junctional hemorrhage, which currently accounts for a staggering 60% of fatalities in military trauma cases. Current data shows that 87% of military fatalities occur in the prehospital environment, proving the need for an accessible, portable, minimally invasive, and effective tool to aid in the urgent care of those wounded.
There are numerous general surgical applications for the SCureClamp with iDOT, including bariatric, cardiac and oncology.
- Vein Physicians
- General Surgeons
- Vascular Surgeons
- Cardiovascular Surgeons
- Interventional Radiologists
- Military Medical Personnel/Emergency Medical Technicians